News from the Canadian Cardiovascular Congress 2014: Long-term weight gain found to trigger the first step in the development of arterial disease, independent of other risk factors.
The Heart Institute ranks 4th in Canada and 159th in the world across all fields of study.
Federal funding will establish Canadian Medical Devices Commercialization Centre at UOHI.
A Harvard University study illustrates the human cost of our over-developed taste for salt.
Substance similar to an African arrow poison could lead to new treatments for hypertension and heart failure.
The PCSK9 protein, much promoted as the target for a new class of cholesterol-lowering drugs, is found at higher levels in patients undergoing a heart attack.
First-ever Canadian survey of women’s attitudes and knowledge about heart disease reveals major gaps between what they know and what they think they know.
Finding a gene associated with disease is one thing. Figuring out what it does is something else. After five years, Heart Institute researchers now know how one genetic variant works and suspect that it contributes to heart disease through processes that promote chronic inflammation and cell division.
Leading figures from across North America came together at the Ottawa Heart Research Conference for a lively look at personalized medicine and heart disease.